We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTO
8751
DELISTED
Altamira Therapeutics Ltd
CYTO
$11K ﹤0.01%
3
-4
-57% -$20.4K
IFMK
8752
DELISTED
iFresh Inc. Common Stock
IFMK
$11K ﹤0.01%
+13,198
New +$19.1K
GNMX
8753
DELISTED
Aevi Genomic Medicine Inc
GNMX
$11K ﹤0.01%
15,774
-1,022
-6% -$1.14K
AMR
8754
PUT
DELISTED
Alta Mesa Resources Inc
AMR
$11K ﹤0.01%
+10,900
New +$27.6K
EPE
8755
DELISTED
EP Energy Corporation
EPE
$11K ﹤0.01%
14,619
+965
+7% +$1.44K
GNCA
8756
DELISTED
Genocea Biosciences, Inc.
GNCA
$11K ﹤0.01%
+4,989
New +$24.8K
CTIC
8757
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$11K ﹤0.01%
15,100
-9,800
-39% -$16.1K
GSAT icon
8758
CALL
Globalstar
GSAT
$10.8B
$10K ﹤0.01%
1,080
-307
-22% -$1.83K
AGIG
8759
Abundia Global Impact Group
AGIG
$38.4M
$10K ﹤0.01%
+408
New +$11.3K
IZEA icon
8760
IZEA Worldwide
IZEA
$53.8M
$10K ﹤0.01%
+2,606
New +$15.1K
PDSB icon
8761
CALL
PDS Biotechnology
PDSB
$13M
$10K ﹤0.01%
+1,630
New +$21.6K
PRSO icon
8762
Peraso
PRSO
$10.3M
$10K ﹤0.01%
77
+46
+148% +$8.57K
RGLS
8763
DELISTED
Regulus Therapeutics
RGLS
$10K ﹤0.01%
+1,067
New +$17.7K
VERO
8764
DELISTED
Venus Concept
VERO
$10K ﹤0.01%
+10
New +$38.4K
YTEN
8765
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$10K ﹤0.01%
13
-17
-57% -$20.8K
MLNT
8766
PUT
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$10K ﹤0.01%
2,520
-1,580
-39% -$20.2K
HLTH
8767
CALL
DELISTED
Nobilis Health Corp.
HLTH
$10K ﹤0.01%
+22,700
New +$13.4K
ARCW
8768
DELISTED
ARC Group Worldwide, Inc
ARCW
$10K ﹤0.01%
+10,424
New +$16K
VRML
8769
DELISTED
Vermillion, Inc.
VRML
$10K ﹤0.01%
+32,080
New +$16.4K
ARMP icon
8770
Armata Pharmaceuticals
ARMP
$158M
$9K ﹤0.01%
3,095
+584
+23% +$2.85K
CLDX icon
8771
Celldex Therapeutics
CLDX
$3.52B
$9K ﹤0.01%
3,105
-5,530
-64% -$27.2K
GURE
8772
Gulf Resources
GURE
$5.48M
$9K ﹤0.01%
+241
New +$10.6K
MLSS icon
8773
Milestone Scientific
MLSS
$48.9M
$9K ﹤0.01%
27,322
+10,736
+65% +$5.75K
MVIS icon
8774
CALL
Microvision
MVIS
$89.7M
$9K ﹤0.01%
973
-3,747
-79% -$52.7K
PLUR icon
8775
PUT
Pluri
PLUR
$17.5M
$9K ﹤0.01%
+149
New +$12.8K

Similar funds

Ken Griffin's Q4 2018 Portfolio in Review

As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.

  • Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Ken Griffin opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.